John M. Fluke Jr. - 15 Jun 2021 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Director
Signature
/s/ Glenna Mileson, attorney-in-fact on behalf of John M. Fluke
Issuer symbol
ATHA
Transactions as of
15 Jun 2021
Net transactions value
$0
Form type
4
Filing time
16 Jun 2021, 18:50:10 UTC
Previous filing
01 Jun 2021
Next filing
27 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATHA Common Stock Other $0 -3,000 -45% $0.000000 3,731 15 Jun 2021 Fluke Capital Management, L.P. F1, F2, F3
transaction ATHA Common Stock Other $0 +1,000 +0.7% $0.000000 144,884 15 Jun 2021 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fluke Capital Management, L.P. distributed these shares to its partners on a pro rata basis for no consideration (the "Distribution").
F2 The Reporting Person disclaims beneficial ownership of the shares of common stock reported herein except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F3 The Reporting Person is a director of Fluke Management Corp., which is the managing general partner of Fluke Capital Management, L.P. The Reporting Person is also a partner of Fluke Capital Management, L.P. By virtue of such relationships, Mr. Fluke may be deemed to have voting and investment power with respect to the shares held by Fluke Capital Management, L.P. and as a result may be deemed to have beneficial ownership of such shares.
F4 Acquisition by the Reporting Person pursuant to the Distribution.